Namzaric (Memantine/Donepezil) for the Treatment of Alzheimer's Disease

Namzaric (memantine/donepezil) is the first fixed-dose combination drug approved for the treatment of moderate and severe Alzheimer's disease in the US.
Source: Drug Development Technology - Category: Pharmaceuticals Source Type: news